Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
August 14, 2013
Neandertals made the first specialized bone tools in Europe
Marie Soressi, Shannon P McPherron, Michel Lenoir, et al.
Blood Advances
|
June 4, 2026
Phase 2a randomized study to evaluate sapablursen in patients with non-transfusion dependent β-thalassemia intermedia
Ali Taher, Michael D Diamantidis, Antonis Kattamis, et al.
Epilepsy & Behavior : E&B
|
January 15, 2020
The 5th International Lafora Epilepsy Workshop: Basic science elucidating therapeutic options and preparing for therapies in the clinic
Matthew S Gentry, Zaid Afawi, Dustin D Armstrong, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
December 17, 2025
Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trial
Michal Geva, Y Paul Goldberg, Melanie L Leitner, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 16, 2012
Context and dating of Aurignacian vulvar representations from Abri Castanet, France
Randall White, Romain Mensan, Raphaëlle Bourrillon, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 4, 2012
Discovery of benzylisothioureas as potent divalent metal transporter 1 (DMT1) inhibitors
Zaihui Zhang, Vishnumurthy Kodumuru, Serguei Sviridov, et al.
Science (New York, N.Y.)
|
January 16, 2007
Early Upper Paleolithic in Eastern Europe and implications for the dispersal of modern humans
M V Anikovich, A A Sinitsyn, John F Hoffecker, et al.
Nature Communications
|
May 21, 2025
Pleistocene chronology and history of hominins and fauna at Denisova Cave
Zenobia Jacobs, Elena I Zavala, Bo Li, et al.
Nature Medicine
|
September 5, 2025
Pridopidine in early-stage manifest Huntington's disease: a phase 3 trial
Ralf Reilmann, Andrew Feigin, Anne E Rosser, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 23, 2023
Potent, Gut-Restricted Inhibitors of Divalent Metal Transporter 1: Preclinical Efficacy against Iron Overload and Safety Evaluation
Alison Cutts, Sultan Chowdhury, Laszlo G Ratkay, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
Proceedings of the National Academy of Sciences of the United States of America
|
August 14, 2013
Neandertals made the first specialized bone tools in Europe
Marie Soressi, Shannon P McPherron, Michel Lenoir, et al.
Blood Advances
|
June 4, 2026
Phase 2a randomized study to evaluate sapablursen in patients with non-transfusion dependent β-thalassemia intermedia
Ali Taher, Michael D Diamantidis, Antonis Kattamis, et al.
Epilepsy & Behavior : E&B
|
January 15, 2020
The 5th International Lafora Epilepsy Workshop: Basic science elucidating therapeutic options and preparing for therapies in the clinic
Matthew S Gentry, Zaid Afawi, Dustin D Armstrong, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
December 17, 2025
Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trial
Michal Geva, Y Paul Goldberg, Melanie L Leitner, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 16, 2012
Context and dating of Aurignacian vulvar representations from Abri Castanet, France
Randall White, Romain Mensan, Raphaëlle Bourrillon, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 4, 2012
Discovery of benzylisothioureas as potent divalent metal transporter 1 (DMT1) inhibitors
Zaihui Zhang, Vishnumurthy Kodumuru, Serguei Sviridov, et al.
Science (New York, N.Y.)
|
January 16, 2007
Early Upper Paleolithic in Eastern Europe and implications for the dispersal of modern humans
M V Anikovich, A A Sinitsyn, John F Hoffecker, et al.
Nature Communications
|
May 21, 2025
Pleistocene chronology and history of hominins and fauna at Denisova Cave
Zenobia Jacobs, Elena I Zavala, Bo Li, et al.
Nature Medicine
|
September 5, 2025
Pridopidine in early-stage manifest Huntington's disease: a phase 3 trial
Ralf Reilmann, Andrew Feigin, Anne E Rosser, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 23, 2023
Potent, Gut-Restricted Inhibitors of Divalent Metal Transporter 1: Preclinical Efficacy against Iron Overload and Safety Evaluation
Alison Cutts, Sultan Chowdhury, Laszlo G Ratkay, et al.
Page
of 9